It is therefore expected that patients with sporadic MSI-H colorectal cancers that develop cancer as a consequence of two somatic MMR gene mutations [25–28] will not harbour MMR-deficient crypt foci in the colon mucosa, similar to our observation in patients with MLH1-hypermethylated cancers. Here, MLH1 is linked to cancer.